by John Conrad | Aug 20, 2025 | iBIO News, Policy News
The Illinois Biotechnology Innovation Organization (iBIO) delivered a coalition lettercoalition letter signed by 74 companies and organizations from across Illinois to the state’s U.S. Congressional delegation, urging immediate action to reauthorize the Small Business...
by John Conrad | Aug 14, 2025 | iBIO News
The latest Government Bioscience Grants (GBG) report from G2G Consulting identifies 78 non-dilutive funding opportunities across critical biotech research areas. Key Opportunities Combat Medicine: DARPA’s MASH program seeks autonomous technologies for finding...
by John Conrad | Aug 5, 2025 | iBIO News
Report highlights nearly 100 life science companies and investment trends as Chicago prepares to welcome BIO International Convention 2030 CHICAGO, IL – August 5, 2025 – The Illinois Biotechnology Innovation Organization (iBIO) today released its inaugural Member...
by John Conrad | Apr 22, 2025 | iBIO News
Amritha Praveen, a sophomore at Adlai E. Stevenson High School, has been named the champion of the 2025 Illinois BioGENEius Challenge. Praveen impressed the panel of industry judges with her groundbreaking research project titled “Early Risk Assessment of Autism...
by John Conrad | Mar 12, 2025 | Grants, iBIO News
In partnership with G2G Consulting, iBIO is pleased to provide members with the March 2025 Government Bioscience Grants (GBG) report. This month’s report identifies 105 non-dilutive funding opportunities despite the challenging federal funding environment. With...
by John Conrad | Dec 18, 2024 | iBIO News
As Illinois’ life sciences industry continues its remarkable growth trajectory, iBIO President and CEO John Conrad and iBIO Board Chair Ken Johnson, Senior Vice President of Global Development and Medical Affairs at Xeris Pharmaceuticals, sat down to discuss the...
